FOLLICULAR DENDRITIC CELLS INHIBIT APOPTOSIS IN HUMAN B-LYMPHOCYTES BY A RAPID AND IRREVERSIBLE BLOCKADE OF PREEXISTING ENDONUCLEASE

被引:68
作者
LINDHOUT, E [1 ]
LAKEMAN, A [1 ]
DEGROOT, C [1 ]
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT CELL BIOL & HISTOL, CELLULAR IMMUNOL GRP, 1100 DE AMSTERDAM, NETHERLANDS
关键词
D O I
10.1084/jem.181.6.1985
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During germinal center reactions, a minority of B lymphocytes are selected after successful binding to follicular dendritic cells (FDCs). The majority of the B cells, however, die by apoptosis. One of the characteristics of apoptosis is rapid fragmentation of DNA by an endogenous endonuclease. The regulation of apoptosis and endonuclease activity in germinal center (GC) B cells is largely unknown. In this study we have investigated the induction and inhibition of endonuclease activity in GC B cells. We also investigated the role of FDCs, surface Ig (sig), sIgM, CD21, CD22, CD40, and intracellular Zn2+ in the regulation of endonuclease activity. We have found that DNA fragmentation in GC B cells is caused by a preexisting endonuclease very similar to NUC-18 (an 18-kD endonuclease identified in rat thymocytes). Endonuclease activity in GC B cells appears to be rapidly and irreversibly blocked after interaction with FDCs, but not after crosslinkage of sIg, sIgM, CD21, CD22, or CD40. Addition of soluble CD40-human IgM fusion protein (sCD40) to FDC-B cell cultures also did not interfere with FDC-mediated B cell rescue. Chelation of intracellular Zn2+ during FDC-B cell cultures resulted in abrogated B cell rescue. These data suggest that FDCs inhibit apoptosis in GC B cells by a rapid inactivation of preexisting endonuclease using a mechanism distinct from CD40 ligation.
引用
收藏
页码:1985 / 1995
页数:11
相关论文
共 59 条
  • [1] ARENDS MJ, 1990, AM J PATHOL, V136, P593
  • [2] LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40
    BANCHEREAU, J
    DEPAOLI, P
    VALLE, A
    GARCIA, E
    ROUSSET, F
    [J]. SCIENCE, 1991, 251 (4989) : 70 - 72
  • [3] BONNEFOY JY, 1993, EUR J IMMUNOL, V23, P969
  • [4] ACTIVATION OF HUMAN B-CELLS MEDIATED THROUGH 2 DISTINCT CELL-SURFACE DIFFERENTIATION ANTIGENS, BP35 AND BP50
    CLARK, EA
    LEDBETTER, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) : 4494 - 4498
  • [5] COHEN JJ, 1991, ADV IMMUNOL, V50, P55
  • [6] COHEN JJ, 1984, J IMMUNOL, V132, P38
  • [7] COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411
  • [8] COTTER TG, 1990, ANTICANCER RES, V10, P1153
  • [9] COTTER TG, 1992, ANTICANCER RES, V12, P773
  • [10] DANG LH, 1991, J IMMUNOL, V146, P3273